From todays announcement.......
Dr Dana C Hilt, Actinogen’s Chief Medical Officer, said:
“Thanks to the extensive data pointing to an active target dose range of 5 to 10mg daily, we are confident that
the current phase 2 clinical trials studying 10mg daily vs. placebo can generate the confirmatory data needed
to progress into further pivotal trials and toward eventual regulatory approvals.”
Note.." CONFIDENT "
EU regulators reject Leqembi for Alzheimers, page-13
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
-0.001(2.63%) |
Mkt cap ! $100.3M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.9¢ | 3.6¢ | $281.6K | 7.556M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1131058 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 660895 | 6 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |